Add Yahoo as a preferred source to see more of our stories on Google. Millions of people take a daily low-dose aspirin, even though they are not at risk of heart disease. (Getty Images) (spxChrome via ...
Add Yahoo as a preferred source to see more of our stories on Google. Low-dose aspirin may lower the risk of heart attack, stroke, and death in adults with Type 2 diabetes. (CREDIT: Shutterstock) For ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." You may have heard that taking a low dose of aspirin every day can boost your heart health. Last year, ...
While ovarian cancer can show symptoms, they are usually subtle and they're often mistaken for other problems. Experts say that's why so many women aren't diagnosed at an early stage. Now, researchers ...
A new study shows daily aspirin use doesn’t impact cancer incidence but may raise the risk of cancer-related mortality. coldsnowstorm/Getty Images In a new study, researchers say aspirin should not be ...
You may have heard that taking a low dose of aspirin every day can boost your heart health. Last year, the American Heart Association reported that more than 48% of U.S. adults age 20 and up have some ...
Low-dose aspirin use is associated with a reduced risk for colorectal cancer (CRC), confirms a large-scale cohort study, which also suggests that the risk reduction is greatest for metastatic disease ...
An aspirin a day may keep the doctor away. It may also reduce your chances of dying from cancer, according to a study on long-term regular aspirin use and different kinds of cancer. Yin Cao, an ...
DEAR DR. ROACH: My wife and I are both healthy and in our 70s. At 5 feet, 9 inches tall, we are both at a reasonable weight. Our yearly blood panels always come back with good results. We both take ...
About 75% of pregnant patients at risk for preeclampsia are not taking low-dose aspirin, the recommended preventive treatment, according to research presented at the American College of Cardiology ...
Low-dose aspirin significantly reduced colorectal cancer recurrence in patients with PI3K pathway gene alterations, nearly halving recurrence rates over three years compared to placebo. The study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results